HCA
39
-7
PGR
53
-10
CMS
58
-3
AXP
44
-2
SWN
42
-4
TRV
43
-6
PG
51
-2
CRM
62
-3
APD
47
-3
XRX
28
-4
AME
54
-3
NFLX
39
-3
MNST
57
-2
EQIX
52
-2
MO
53
-3
COF
28
-2
ADBE
46
2
AAPL
50
-3
PYPL
33
8
AMZN
52
-4
HCA
39
-7
PGR
53
-10
CMS
58
-3
AXP
44
-2
SWN
42
-4
TRV
43
-6
PG
51
-2
CRM
62
-3
APD
47
-3
XRX
28
-4
AME
54
-3
NFLX
39
-3
MNST
57
-2
EQIX
52
-2
MO
53
-3
COF
28
-2
ADBE
46
2
AAPL
50
-3
PYPL
33
8
AMZN
52
-4
Financhill
Back

NovoCure Stock Price Chart

An instant "bonus payout" courtesy of Mr. Market?

All thanks to a method most investors have no idea about watch this demo showing how it works.
Sell
44

NVCR
NovoCure

Last Price:
57.10
Seasonality Move:
31.19%

7 Day Trial

ALL ACCESS PASS

$ 7

How He Bagged One Of The Top Trading Records

Click to see this exclusive sit-down interview
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVCR is experiencing selling pressure, which indicates risk of future bearish movement.

NovoCure Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 66.69 Sell
20-day SMA: 73.53 Sell
50-day SMA: 84.7 Sell
200-day SMA: 77.91 Sell
8-day EMA: 66.03 Sell
20-day EMA: 72.48 Sell
50-day EMA: 78.36 Sell
200-day EMA: 81.22 Sell

NovoCure Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.92 Sell
Relative Strength Index (14 RSI): 20.1 Sell
Chaikin Money Flow: -1024338 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (68.19 - 84.11) Sell
Bollinger Bands (100): (69.44 - 89.52) Sell

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for NovoCure Stock

Is NovoCure Stock a Buy?

  • NovoCure share price is 57.10 while NVCR 8-day simple moving average is 66.69, which is a Sell signal.
  • The stock price of NVCR is 57.10 while NovoCure 20-day SMA is 73.53, which makes it a Sell.
  • NovoCure 50-day simple moving average is 84.70 while NVCR share price is 57.10, making it a Sell technically.
  • NVCR stock price is 57.10 and NovoCure 200-day simple moving average is 77.91, creating a Sell signal.

NVCR Technical Analysis vs Fundamental Analysis

Sell
44
NovoCure (NVCR) is a Sell

Is NovoCure a Buy or a Sell?

  • NovoCure stock is rated a Sell
    The current NovoCure [NVCR] share price is $57.10. The Score for NVCR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.

NovoCure Stock Info

Market Cap:
6.02B
Price in USD:
57.10
Share Volume:
1.46M

NovoCure 52-Week Range

52-Week High:
120.03
52-Week Low:
56.39
Sell
44
NovoCure (NVCR) is a Sell

NovoCure Share Price Forecast

  • What is the NovoCure stock price today?
    The NovoCure stock price is 57.10 USD today.
  • Will NVCR stock go up or go down?
    NovoCure> share price is forecast to RISE/FALL based on technical indicators
  • Is NovoCure overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovoCure is overvalued.

Is NovoCure Stock a Buy?

  • NovoCure share price is 57.10 while NVCR 8-day exponential moving average is 66.03, which is a Sell signal.
  • The stock price of NVCR is 57.10 while NovoCure 20-day EMA is 72.48, which makes it a Sell.
  • NovoCure 50-day exponential moving average is 78.36 while NVCR share price is 57.10, making it a Sell technically.
  • NVCR stock price is 57.10 and NovoCure 200-day simple moving average is 81.22, creating a Sell signal.

Fundamental Analysis of NovoCure

Is NovoCure a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.16 per share.

Technical Analysis of NovoCure

Should I short NovoCure stock?

  • NVCR Moving Average Covergence Divergence (MACD) indicator is -5.92, suggesting NovoCure is a Sell
  • NovoCure Relative Strength Index (RSI) is 20.1, which suggest NovoCure is oversold
  • The Bollinger Bands (25) for NovoCure is (68.19 - 84.11), which suggest NovoCure is a Sell
  • The Bollinger Bands (100) for NovoCure is (69.44 - 89.52), which suggest NovoCure is a Sell

* NovoCure stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.